Carmen Farrior, MD
Obstetrics & Gynecology · Pikesville, MDNPI 1184735763
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,220 of the $1,389 with a category attached, or 87.8%. It is spread thinly across 17 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $296 and has fallen 81.2% since, to $56 in 2025.
Across 65 payments — averaging $21.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$272
- Mayne Pharma Commercial LLC$203
- AbbVie$173
- Exeltis, USA Inc.$153
- Aspira Women's Health Inc$97
- Sage Therapeutics, LLC$88
- plus $402 from 11 others
What the payments were for
- Food & beverage$1,22088%
- Education$16912%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 9 | $272 |
| Mayne Pharma Commercial LLC | 9 | $203 |
| AbbVie(2 entities) | 10 | $173 |
| Exeltis, USA Inc. | 9 | $153 |
| Aspira Women's Health Inc | 2 | $97 |
| Sage Therapeutics, LLC | 3 | $88 |
| Mylan Pharmaceuticals Inc. | 4 | $75 |
| Lupin Inc. | 3 | $53 |
| Evofem Biosciences, Inc. | 3 | $50 |
| Millicent US Inc | 3 | $46 |
| AMAG Pharmaceuticals, Inc. | 2 | $44 |
| Therapeuticsmd, Inc. | 2 | $37 |
| Myovant Sciences Inc. | 1 | $31 |
| Vertical Pharmaceuticals, LLC | 2 | $26 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Scynexis, Inc. | 1 | $11 |
| Meditrina | 1 | $6 |
How this compares
$1,389 in reported general payments places this provider in the 70th percentile of 842 obstetrics & gynecology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Climara ProEstradiol/Levonorgestrel | 11 | $4,555 |
| ValacyclovirValacyclovir Hcl | 48 | $1,854 |
| ProgesteroneProgesterone, Micronized | 13 | $584 |
| Nystatin | 25 | $397 |
| Terconazole | 13 | $379 |
| Acyclovir | 11 | $334 |
| Fluconazole | 60 | $314 |
| Junel FeNorethindrone-E.Estradiol-Iron | 13 | $265 |
| Metronidazole | 24 | $132 |
| Triamcinolone Acetonide | 13 | $121 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Pikesville
- Otis StittSilver Spring$641K
- Danielle ShillerBaltimore$221K
- Matthew ReevesChevy Chase$149K
- Karen WangBaltimore$91K
- Rebecca StoneBaltimore$88K
- Abigail GregoryOakland$63K
- Christina EnzmannBaltimore$63K
- Lisa RarickChesapeake Beach$54K
- Logan PetersonBethesda$52K
- Latasha MurphyBaltimore$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.